-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
WHO experts remind to pay attention to the long-term impact of the new crown |
Xinhua News Agency, Copenhagen, February 25 (Reporter Lin Jing) The Director of the World Health Organization’s European Regional Office said on the 25th that the rate of new crown infections in Europe has been on the decline.
Kluger said at an online press conference held in Copenhagen that day that one in ten European patients with COVID-19 still had symptoms 12 weeks after healed, and many people’s symptoms would last longer, causing serious social, economic, and economic problems.
Martin McGee, a professor at the University of London School of Hygiene and Tropical Medicine, said at a press conference that "new crown sequelae" are like "different combinations of symptoms", including chest and muscle pain, fatigue, shortness of breath, and what the patient described Cognitive symptoms such as "brain fog.
Klug said that the WHO Regional Office for Europe will hold meetings with health officials from countries in the region to formulate a regional strategy to solve this problem.
Officials aspx?id=3570" target="_blank" style="color:#ba1413">focus on the new crown pneumonia epidemic